Filing Details

Accession Number:
0001562180-22-004014
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-12 20:58:58
Reporting Period:
2022-05-10
Accepted Time:
2022-05-12 20:58:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1878290 C. George Clark C/O Biohaven Pharmaceuticals, Inc.
215 Church Street
New Haven CT 06510
Vp, Chief Accounting Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2022-05-10 2,250 $53.76 8,265 No 4 M Direct
Common Shares Disposition 2022-05-10 4,200 $141.50 4,065 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Employee Stock Option (right to buy) Disposition 2022-05-10 2,250 $0.00 2,250 $53.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,250 2029-12-05 No 4 M Direct
Footnotes
  1. These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
  2. The shares underlying this option vest in four equal installments on December 5, 2019, 2020, 2021 and 2022, subject to the reporting person's continued service with the issuer at each vesting date.